Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lu... by West, Howard, MD, McCleod, Michael, DO, Hussein, Maen, MD, Morabito, Alessandro, MD, Rittmeyer, Achim, MD, Conter, Henry J, MD, Kopp, Hans-Georg, Prof, Daniel, Davey, MD, McCune, Steven, MD, Mekhail, Tarek, MD, Zer, Alona, Prof, Reinmuth, Niels, Prof, Sadiq, Ahad, MD, Sandler, Alan, MD, Lin, Wei, MD, Ochi Lohmann, Tania, PhD, Archer, Venice, MD, Wang, Lijia, PhD, Kowanetz, Marcin, MD, Cappuzzo, Federico, Prof

Get full text

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updat... by Goldman, Jonathan W, MD, Dvorkin, Mikhail, MD, Chen, Yuanbin, MD, Reinmuth, Niels, MD, Hotta, Katsuyuki, Prof, Trukhin, Dmytro, MD, Statsenko, Galina, MD, Hochmair, Maximilian J, MD, Özgüroğlu, Mustafa, Prof, Ji, Jun Ho, MD, Garassino, Marina Chiara, MD, Voitko, Oleksandr, MD, Poltoratskiy, Artem, MD, Ponce, Santiago, MD, Verderame, Francesco, MD, Havel, Libor, MD, Bondarenko, Igor, Prof, Każarnowicz, Andrzej, MD, Losonczy, György, Prof, Conev, Nikolay V, MD, Armstrong, Jon, MSc, Byrne, Natalie, BSc, Thiyagarajah, Piruntha, MD, Jiang, Haiyi, MD, Paz-Ares, Luis, Prof

Get full text